Pfizer and BioNTech Will Sell 500 Million Covid Vaccine Doses to the U.S. for Global Distribution

Pfizer and BioNTech Will Sell 500 Million Covid Vaccine Doses to the U.S. for Global Distribution
·3 min read

The deal comes as global concern grows over a new Covid-19 variant, designated the Delta variant, that is thought to have played a role in the outbreak in India this spring.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting